Skip to content

NHS Payment Reconciliation (FP34)

Your pharmacy income is a contract, not a till. Reconcile it accordingly.

The FP34 is the monthly claim that turns your NHS dispensing into income, and we reconcile it for community pharmacies anywhere in England. Your NHS income is reimbursement at Drug Tariff prices plus fees and service payments under the Community Pharmacy Contractual Framework, so it doesn't behave like shop takings. NHSBSA pays an estimated 100% advance around the 10th of the month after you dispense, then settles the difference about two months after you submit, and the FP34 Schedule of Payment arrives about 5 working days before each payment. Each month we match that schedule to your claim, your bank and your ledger, chase anything that doesn't agree, track your margin as Category M prices move each quarter, and model the cash you need before the advance lands.

100% advance
NHSBSA pays an estimated 100% advance around the 10th of the month after you dispense, if you've declared by the 5th. The reconciliation follows about two months after you submit.
Category M
DHSC sets Category M prices each quarter. You're paid the Drug Tariff price for the month you dispense; margin above the funded level is recouped through future prices, not at the till
Pharmacy First
Paid per consultation, with a monthly fixed payment on top once you reach 20 consultations, so it's worth its own line in your books, apart from dispensing

NHS Payment Reconciliation (FP34)

The challenges clients face.

The FP34 lag creates a real working-capital gap

Because the advance is an estimate of 100% of the month's claim, you aren't waiting two months for your money. But the gap doesn't close. You buy October's stock and pay October's wages before the advance lands around 10 November, and if NHSBSA prices the claim below its estimate, the overestimate comes back out of the next advance. Declare after the 5th and the advance moves to the next payment run (1 December for October 2026 dispensing, if NHSBSA has your claim by 23 November). Any later and there's no advance at all: you're paid with the reconciliation. That's the gap we model, and it grows with your item volume.

Contract-driven income is not retail income

NHS reimbursement follows the Drug Tariff, and remuneration follows the CPCF fee schedule. Neither is the same as taking money across the counter. A pharmacy income statement that lumps NHS income with OTC retail, or that does not separately account for service income, is wrong at the source. This leads to incorrect tax computations, incorrect VAT returns, and a management view that does not reflect the business.

Category M clawback moves margin quarter by quarter

Category M prices aren't changed after you dispense. DHSC sets them each quarter from suppliers' price information, and you're paid the price listed in the Drug Tariff for the month you dispense. 'Clawback' is the trade word for recouping margin above the level the contract funds, and it works through lower Category M prices in later quarters. The 2026/27 settlement writes off £219 million of confirmed historic over-delivery (£166 million net of fee under-delivery), with up to £73 million more for the second half of 2025/26 subject to the margin survey, and makes no price adjustments in 2026/27 to recover what's left. So your margin moves quarter by quarter with the Tariff, which is what a monthly variance check catches. Our guide to how Category M prices are set has the detail.

Pharmacy First income needs separate tracking

Pharmacy First is paid per consultation, with fixed monthly payments once you pass set thresholds, so it's a separately structured revenue line. Its activity goes into your advance through your average item value rather than as a separate advance fee, which makes the schedule harder to read. Lumping it in with dispensing reimbursement hides what the service earns you and muddles the income for management accounts and tax.

NHS Payment Reconciliation (FP34)

How we help.

01

Monthly FP34 reconciliation and ledger matching

Each month we take your FP34 Schedule of Payment, which NHSBSA sends about 5 working days before payment, and match it to the claim you declared, to the bank and to your ledger. We post the advance and the reconciliation payment as what they are, an estimate and the settlement, and flag any line that doesn't agree. If something's out, we find it that month, not at year-end.

02

Drug Tariff margin variance analysis

We track your gross margin on NHS dispensing against the Tariff each month, show where Category M price changes and price concessions moved it, and produce a margin-variance report designed for a pharmacy operator, not just an accountant. It's the monthly view that tells you what changed while there's still time to act on it.

03

Working-capital modelling and Pharmacy First accounting

We use our FP34 cash-flow estimator to set the advance and reconciliation dates against when you pay your wholesaler and your staff, so you'll see the cash you need before the advance arrives rather than discover a shortfall. We keep Pharmacy First and other service income on its own line, so the income is right for both management reporting and tax. You can run the estimator yourself before you get in touch.

Common questions

The FP34 is your monthly NHS prescription claim: you send NHSBSA the month's prescriptions and declare the totals on the FP34C through Manage Your Service (MYS) by the 5th of the following month. Do that and NHSBSA pays an estimated 100% advance around the 10th, then the reconciliation for the difference about two months after you submit. For October 2026 dispensing that's 11 November and 31 December. If the advance was too high, NHSBSA takes the overestimate back from the next advance. The cash you need is the stock and wages you pay before the advance lands, which our FP34 cash-flow estimator sets out for a month's dispensing. Our guide to the FP34 payment cycle walks through the dates and the schedule.

Because nobody at the counter sets the price. NHS dispensing income is reimbursement at Drug Tariff prices, and remuneration is a fee under the Community Pharmacy Contractual Framework, both paid by NHSBSA on its own timetable. Neither is shop takings. Your margin moves when DHSC changes Category M prices each quarter, not when you change a shelf price. That's why we book NHS income, retail takings and service income on separate lines: it's what gets the margin, the VAT return and the tax computation right.

Category M covers generic medicines that are readily available. DHSC sets their Drug Tariff prices each quarter from suppliers' price information, and the month you dispense fixes the price you're paid: nothing is repriced afterwards. The 'clawback' is how margin above the level the contract funds gets recouped, through lower Category M prices in later quarters. For 2026/27, the settlement writes off £219 million of confirmed historic over-delivery (£166 million net of fee under-delivery), with up to £73 million more for the second half of 2025/26 subject to the margin survey, and makes no price adjustments in 2026/27 to recover what's left. In your accounts it shows up as margin that moves with each quarter's prices, so we check it against the Tariff every month.

As its own revenue line, apart from dispensing reimbursement and the other fees, with its own costs where you can attribute them. In 2026/27 each Pharmacy First clinical pathway consultation pays £17, plus a fixed payment of £500 in a month with 20 to 29 consultations or £1,000 at 30 or more (CPCF 2026/27 letter). Keeping it separate shows what the service earns for the time it takes, and it's what keeps the VAT on the medicines and the consultations straight: our guide to VAT on Pharmacy First and private services covers that.

Speak to a pharmacy finance specialist.

Tell us about your situation and we will reply within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)